More like this
- Conflicts of interest rarely discussed in influential mega-analyses of drug treatments, study finds
- When you're told a drug is safe and effective, you might want to ask, 'Says who?'
- Study adds fuel to controversy about whether cholesterol-lowering drugs benefit low-risk individuals
- U of M's private research guidelines break new ground -- and bow to new realities
- Health advocacy groups often fail to report Big Pharma grants, report finds
PreferredOne customers will face rate hikes on MNsure. How much? A lot less than 63% — and a lot more than 4.524 comments